🩸 MYLeukaemia is a research project that aims to drive the future of cancer therapy beyond current patient trial-and-error treatments with the design of the next generation of functional ex vivo drug testing powered by cutting-edge Organ-on-Chip technology. 🚀
💉 With MYLeukaemia Organ-on-Chip platform we expect to advance knowledge on residual disease emergence in distinct leukaemia subtypes; and translate it into the development of new prognostic markers & therapeutic targets for Leukaemia eradication. 🎯
🌱 This entrepreneurship venture originated in an Foundation for Science and Technology (FCT)-funded R&D project and gathers scientific experts in the fields of both clinical and experimental leukaemia, cancer drug resistance, tissue engineering, biomaterials, microfluidics, proteomics & bioinformatics analysis in a cohesive and transdisciplinary approach taking on the challenge to drive functional precision medicine in Leukaemia care. 🧬
📢 This LinkedIn page is a space to share our research and our members’ knowledge with the open community. Keep an eye out for our upcoming posts! 👀
Company Details
- Employees
- 1
- Address
- Rua Alfredo Allen, 455,461,portugal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Show more similar pages.
- HQ
- Paranhos, Porto
Myleukaemia Project Questions
Myleukaemia Project's LinkedIn profile is https://pt.linkedin.com/company/myleukaemia
Myleukaemia Project has
1 employees.
View email and phone details for 1
employees at Myleukaemia Project.
Myleukaemia Project's industry is
Biotechnology Research
Myleukaemia Project's top competitors are
Blood2power,
Pfx Biotech, Lda,
Silicolife,
Beat Therapeutics,
Fetalix,
Gotech Antimicrobial,
Ilof,
Corium Biotech,
I3s - Instituto De Investigação E Inovação Em Saúde,
Databiomics.
Myleukaemia Project's categories are Biotechnology Research
